ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, featuring promising developments across a variety of clinical and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA provides a safer, far more reliable different for therapeutic use